DSM to acquire Vitatene S.A.U. to expand position in natural carotenoids
The transaction is subject to regulatory and other customary approvals and notifications and is expected to close by the end of Q2 2011. Financial details of the acquisition will not be disclosed at this time.
Founded in 2004, Vitatene is a leader in the production and sale of a range of high-value natural carotenoid products derived from fermentation of the fungus Blakeslea trispora. The products are sold under the brandnames Betanat and Lyconat. The products are an addition to DSM's current portfolio of highly functional carotenoids, ranging from beta-carotene to lutein and zeaxanthin.
Leendert Staal, President and CEO of DSM Nutritional Products, said: "This acquisition fits perfectly with our strategy "DSM in motion: driving focused growth". Consumer demand for natural products continues to grow. Vitatene is an excellent fit with DSM's current product portfolio and technological capabilities and will allow us to drive the growth in natural carotenoids."
Carlo Pizzocaro, CEO of P&R Group, said: "It is great that we have found such a strong new home for Vitatene's business. We believe this is excellent news for our customers and Vitatene's staff. We will work with DSM to make the transfer as smooth as possible to guarantee business continuity for our customers and thank them for their loyalty."
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.